---
title: "Reducing Risk, Enhancing Flexibility: Lonza’s Approach to Custom Media Manufacturing"
description: In this webinar, Lonza will showcase how their custom media manufacturing service addresses barriers through GMP-compliance, and more.
---

[![BPI Media_Logo 2_Color 1](https://bpi.bioprocessintl.com/hs-fs/hubfs/BPI%20Media_Logo%202_Color%201.png?width=350&height=161&name=BPI%20Media_Logo%202_Color%201.png)](https://bioprocessintl.com/)

# ![ATE-Logo-2024-1](https://bpi.bioprocessintl.com/hs-fs/hubfs/ATE-Logo-2024-1.png?width=590&height=204&name=ATE-Logo-2024-1.png)

# Reducing Risk, Enhancing Flexibility:

# Lonza’s Approach to Custom Media Manufacturing

|  |
| --- |

## Presenters:

****![07-24-2025-Lonza-ATE-Speaker-HS-Cropped](https://bpi.bioprocessintl.com/hs-fs/hubfs/07-24-2025-Lonza-ATE-Speaker-HS-Cropped.png?width=150&height=205&name=07-24-2025-Lonza-ATE-Speaker-HS-Cropped.png)****

**Jessica Pickrell **

*Associate Director of GMP Media Strategy,*

Lonza 

 

Jessica has over 10 years experience in life sciences cell culture and commercial roles, from small benchtop scale to large commercial manufacturing solutions. She currently manages the global GMP media portfolio at Lonza, looking to provide better solutions for  customers that reduce risk and burden and increase titers and productivity across all advanced modalities.

## About this event:

#### Date: July 24, 2025

#### Time: 11 am EDT | 8 am PDT | 5 pm CEST

#### Duration: 30 minutes

Scaling biologics programs comes with complex media manufacturing decisions from maintaining IP protection to ensuring consistent quality across global production sites. Many biomanufacturers face challenges such as limited internal capacity, vendor reliability concerns, and lack of flexibility from traditional suppliers.

In this webinar, Lonza will showcase how their custom media manufacturing service addresses these barriers through GMP-compliance, scalable production, reliable global supply, and their decades of CDMO expertise. You’ll also hear real world case studies of how they've supported seamless media transitions, mitigated manufacturing risks, and accelerated time-to-market.

Whether you're optimizing CHO media for clinical supply or preparing for commercial launch, discover how Lonza delivers flexible, scalable solutions while minimizing risk, maximizing control, and ensuring long-term success.

-  

-  

©2015 BioProcess International All Rights reserved